Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indresh K Srivastava

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Expert Review of Vaccines|November 26, 2010
Novel adjuvants and delivery systems for enhancing immune responses induced by immunogensAntu K Dey, Indresh K Srivastava
Annals of Internal Medicine|April 2, 2003
Gene vaccinesIndresh K Srivastava, Margaret A Liu
Human Vaccines|October 14, 2006
Role of neutralizing antibodies in protective immunity against HIVIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Expert Review of Vaccines|August 3, 2004
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine designIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Journal of Virology|January 29, 2003
Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable regionIndresh K Srivastava, Keating VanDorsten, Lucia Vojtech, et al.
Advances in Biochemical Engineering/Biotechnology|June 11, 2018
Glycobiotechnology of the Insect Cell-Baculovirus Expression System TechnologyLaura A Palomares, Indresh K Srivastava, Octavio T Ramírez, et al.
Microbes and Infection|November 9, 2005
Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and CSusan W Barnett, Indresh K Srivastava, Jeffrey B Ulmer, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2007
Direct inactivation of human immunodeficiency virus type 1 by a novel small-molecule entry inhibitor, DCM205Yen T Duong, D Christopher Meadows, Indresh K Srivastava, et al.
Biotechnology and Bioengineering|May 7, 2015
Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cellsJamal Meghrous, Nikolai Khramtsov, Barry C Buckland, et al.
Vaccine|September 28, 2015
Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolateDavid G Rhodes, Kathy Holtz, Pam Robinson, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Expert Review of Vaccines|November 26, 2010
Novel adjuvants and delivery systems for enhancing immune responses induced by immunogensAntu K Dey, Indresh K Srivastava
Annals of Internal Medicine|April 2, 2003
Gene vaccinesIndresh K Srivastava, Margaret A Liu
Human Vaccines|October 14, 2006
Role of neutralizing antibodies in protective immunity against HIVIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Expert Review of Vaccines|August 3, 2004
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine designIndresh K Srivastava, Jeffrey B Ulmer, Susan W Barnett
Journal of Virology|January 29, 2003
Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable regionIndresh K Srivastava, Keating VanDorsten, Lucia Vojtech, et al.
Advances in Biochemical Engineering/Biotechnology|June 11, 2018
Glycobiotechnology of the Insect Cell-Baculovirus Expression System TechnologyLaura A Palomares, Indresh K Srivastava, Octavio T Ramírez, et al.
Microbes and Infection|November 9, 2005
Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and CSusan W Barnett, Indresh K Srivastava, Jeffrey B Ulmer, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2007
Direct inactivation of human immunodeficiency virus type 1 by a novel small-molecule entry inhibitor, DCM205Yen T Duong, D Christopher Meadows, Indresh K Srivastava, et al.
Biotechnology and Bioengineering|May 7, 2015
Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cellsJamal Meghrous, Nikolai Khramtsov, Barry C Buckland, et al.
Vaccine|September 28, 2015
Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolateDavid G Rhodes, Kathy Holtz, Pam Robinson, et al.
Pageof 4